TBPH (Theravance Biopharma) Short-Term Debt to Capital

Corporate company logo of Theravance Biopharma (TBPH)

The global distribution of respiratory treatments relies on established supply chains, ensuring medication availability in pharmacies. The price trend on GURU.Markets, where the indicator equals 0.03, links logistics to partnerships with industry behemoths for joint product promotion. Meanwhile, steady demand for lung treatments ensures a stable cash flow, supporting the operational activity of Theravance Biopharma (TBPH).

Ratio of Short-Term Indebtedness to Capital: Theravance (TBPH) for 07/04/2022 - 10/10/2026

Analytical breakdowns for Theravance Biopharma

- stock quotes and analyst forecast:
Stock Price Theravance|TBPH - Fair Value Consensus
- business market valuation indicators:
Market Capitalization Theravance Biopharma Inc|TBPH - Enterprise Value
- book capitalization information:
Net Assets per Single Share Theravance Biopharma|TBPH - Accounting Value of Company|Market Value to Book Value Ratio theravance.com|TBPH - Cumulative Company Assets
- company liabilities and liquidity data:
Total Debt to Capital Theravance Biopharma|TBPH - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Theravance Biopharma, Inc.|TBPH - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Theravance Biopharma Inc|TBPH - Long-Term Debt|Company Current Liabilities Theravance Biopharma|Quick Ratio theravance.com
- company profitability and valuation multiples indicators:
TBPH - Final Profit
Fundamental valuation:TBPH Theravance
Brand item of Theravance Biopharma Inc

Through partnerships with pharma giants and the receipt of royalties, Theravance Biopharma (TBPH) minimizes operating expenses, which directly impacts its short-term financial leverage ratio. This metric compares liabilities with maturities of up to one year against total equity to measure immediate liquidity and resilience to cash flow gaps, allowing investors to assess the balance between financial security and the efficiency of borrowed fund utilization.

Competitors of Theravance Biopharma (TBPH)

Short-Term Debt to Capital HLN|KVUE (Kenvue Health) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital VRNA (Verona Pharma plc)|Short-Term Debt to Capital jyongbio.com MENS|LGND - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital AMRX (Amneal Pharmaceuticals, Inc.)|Perrigo Company (PRGO) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Alvotech Biopharmaceuticals|LQDA (Liquidia Corporation) - Short-Term Debt to Capital|Short-Term Debt to Capital glpg.com|Short-Term Debt to Equity Ratio ANIP (ANI Pharmaceuticals, Inc.)|MNKD (MannKind Corp) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Amphastar AMPH|Pacira Corp (PCRX) - Current Liabilities to Capital|SPRY: Short-Term Debt to Equity Ratio|aquestive.com - Short-Term Loans to Capital Ratio|SCPH: Short-Term Debt to Capital|Tectonic Therapeutic - Ratio of Short-Term Indebtedness to Capital|TNXP (Tonix Pharmaceuticals Inc.) - Short-Term Debt to Capital|Current Liabilities to Capital SXT China SXTC|Short-Term Debt to Equity Eupraxia Pharmaceuticals (EPRX)|BHST (bioharvest.com) - Ratio of Short-Term Indebtedness to Capital|eXoZymes - Short-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio ORMP (Oramed)|Entera Bio Corp - Short-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital HYFT (MindWalk Therapeutics)|ABVC: Short-Term Debt to Capital|Current Liabilities to Capital cumberlandpharma.com (CPIX)|Short-Term Debt to Equity Quantum BioPharma|FGEN: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital TELO|Short-Term Debt to Capital ranitherapeutics.com (RANI)|Synergy CHC - Short-Term Debt to Equity Ratio|Rallybio Corp - Short-Term Debt to Equity|Lexaria - Short-Term Debt to Capital|PULM - Short-Term Debt to Capital|ftzy.com.cn (PTHL) - Short-Term Debt to Equity|Short-Term Debt to Capital Ratio APM|LYRA (Lyra Therapeutics, Inc.) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio impactbiomedinc.com (IBO)|Short-Term Debt to Capital TNFA|YCBD - Current Liabilities to Capital|PainReform Limited - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital CYTO|Lipella Pharmaceuticals - Short-Term Debt to Capital|OPTN: Short-Term Debt to Equity|PIRS: Short-Term Debt to Capital|PROC - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Petros|Current Liabilities to Capital Qilian International Corp QLI|Short-Term Debt to Equity Acelyrin, Inc. (SLRN)|TFFP: Current Liabilities to Equity